Funder: National Institutes of Health

Due Dates: May 28, 2025 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $1.5 million in annual direct costs for up to 5 years per award

Summary: Supports the renewal and further development of biomedical research centers at IDeA-eligible institutions, enhancing research infrastructure and investigator competitiveness for independent funding.

Key Information: Only institutions with an active COBRE Phase 1 award are eligible; clinical trial optional; limited competition.